KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly
The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace
The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace
A look at why investors should stock up on Amgen, Celldex Therapeutics, and Novavax soon. Source: BioSpace
FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace
The FDA denied a request from Allergan to reject any ANDAs referencing Restasis unless the applicant proves bioequivalence through clinical endpoints. Source: Drug Industry Daily
The Native American tribe that entered a controversial patent deal with Allergan is questioning the impartiality of the Patent Trial and Appeals Board judges charged with reviewing the arrangement. Source:…
The FDA’s Office of Prescription Drug Promotion issued just three warning letters and one untitled letter in calendar year 2017 — a record low and down from a high of…
The additional capital is expected to provide funding to advance avacopan through topline data from the Phase III ADVOCATE trial as well as potential registration filings in the U.S. and…
Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment. Source: BioSpace
The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace
Pfizer will use Arvinas' proprietary PROTAC Platform to create small molecule therapeutics aimed at degrading disease-causing cellular proteins. Source: BioSpace